Cysteine effects on the pharmacokinetics of etoposide in protein–calorie malnutrition rats: increased gastrointestinal absorption by cysteine

References

• Ahn CY, Bae SK, Bae SH, Kim T, Jung YS, Kim YC, Lee MG, Shin WG. (2009). Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis. Br J Pharmacol 156:1019–1028.
   PubMed Web of Science ®Google Scholar
• al-Shawi MK, Urbatsch IL, Senior AE. (1994). Covalent inhibitors of P-glycoprotein ATPase activity. J Biol Chem 269:8986–8992.
   PubMed Web of Science ®Google Scholar
• Bae SK, Lee SJ, Kwon JW, Kim WB, Lee MG. (2004). Effects of protein-calorie malnutrition on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats. J Pharm Pharmacol 56:635–642.
   PubMed Web of Science ®Google Scholar
• Boullata JI. (2010). Drug disposition in obesity and protein-energy malnutrition. Proc Nutr Soc 69:543–550.
   PubMed Web of Science ®Google Scholar
• Buchanan N. (1978). Drug kinetics in protein energy malnutrition. S Afr Med J 53:327–330.
   PubMed Web of Science ®Google Scholar
• Chiou WL. (1978). Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level–time curve. J Pharmacokinet Biopharm 6:539–546.
   PubMedGoogle Scholar
• Cho MK, Kim YG, Lee MG, Kim SG. (1999). Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: complete or partial restoration by cysteine or methionine supplementation. Arch Biochem Biophys 372:150–158.
   PubMed Web of Science ®Google Scholar
• Choi YH, Kim SG, Lee MG. (2006). Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects. J Pharm Sci 95:2543–2552.
   PubMed Web of Science ®Google Scholar
• Clark PI, Slevin ML. (1987). The clinical pharmacology of etoposide and teniposide. Clin Pharmacokinet 12:223–252.
   PubMed Web of Science ®Google Scholar
• Denke M, Wilson JD. (1998). Protein and energy malnutrition. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. Principles of Internal Medicine (14th edn). New York: McGraw-Hill, 452–454.
   Google Scholar
• Föger F, Schmitz T, Bernkop-Schnürch A. (2006). In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan. Biomaterials 27:4250–4255.
   PubMed Web of Science ®Google Scholar
• Gamelli RL, Foster RS Jr. (1983). Effects of protein-calorie malnutrition and refeeding on fluorouracil toxicity. Arch Surg 118:1182–1185.
   PubMedGoogle Scholar
• Gibaldi M, Perrier D, eds. (1982). Pharmacokinetics (2nd edn). New York: Marcel-Dekker.
   Google Scholar
• González-Hernández I, Jung-Cook H, Sotelo A. (2008). Effect of malnutrition on the pharmacokinetics of cefuroxime axetil in young rats. J Pharm Pharm Sci 11:9–21.
   PubMed Web of Science ®Google Scholar
• Guo A, Marinaro W, Hu P, Sinko PJ. (2002). Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT). Drug Metab Dispos 30:457–463.
   PubMed Web of Science ®Google Scholar
• Hande K, Anthony L, Hamilton R, Bennett R, Sweetman B, Branch R. (1988a). Identification of etoposide glucuronide as a major metabolite of etoposide in the rat and rabbit. Cancer Res 48:1829–1834.
   PubMed Web of Science ®Google Scholar
• Hande K, Bennett R, Hamilton R, Grote T, Branch R. (1988b). Metabolism and excretion of etoposide in isolated, perfused rat liver models. Cancer Res 48:5692–5695.
   PubMed Web of Science ®Google Scholar
• Hong H, Lu Y, Ji ZN, Liu GQ. (2006). Up-regulation of P-glycoprotein expression by glutathione depletion-induced oxidative stress in rat brain microvessel endothelial cells. J Neurochem 98:1465–1473.
   PubMed Web of Science ®Google Scholar
• Kaminsky LS, Fasco MJ. (1991). Small intestinal cytochromes P450. Crit Rev Toxicol 21:407–422.
   PubMed Web of Science ®Google Scholar
• Kaminsky LS, Zhang QY. (2003). The small intestine as a xenobiotic-metabolizing organ. Drug Metab Dispos 31:1520–1525.
   PubMed Web of Science ®Google Scholar
• Kim SH, Choi YM, Lee MG. (1993). Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J Pharmacokinet Biopharm 21:1–17.
   PubMedGoogle Scholar
• Kim MK, Han L, Choi MK, Han YH, Kim DD, Chung SJ, Shim CK. (2005). Dose dependency in the oral bioavailability of an organic cation model, tributylmethyl ammonium (TBuMA), in rats: association with the saturation of efflux by the P-gp system on the apical membrane of the intestinal epithelium. J Pharm Sci 94:2644–2655.
   PubMed Web of Science ®Google Scholar
• Krishnaswamy K. (1978). Drug metabolism and pharmacokinetics in malnutrition. Clin Pharmacokinet 3:216–240.
   PubMed Web of Science ®Google Scholar
• Lagas JS, Fan L, Wagenaar E, Vlaming ML, van Tellingen O, Beijnen JH, Schinkel AH. (2010). P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 determine the pharmacokinetics of etoposide. Clin Cancer Res 16:130–140.
   PubMed Web of Science ®Google Scholar
• Lee MG, Chiou WL. (1983). Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism. J Pharmacokinet Biopharm 11:623–640.
   PubMedGoogle Scholar
• Lee YM, Song IS, Kim SG, Lee MG, Chung SJ, Shim CK. (2003). The suppressed expression and functional activity of hepatic P-glycoprotein in rats with protein-calorie malnutrition. J Pharm Sci 92:1323–1330.
   PubMed Web of Science ®Google Scholar
• Lee JH, Suh OK, Lee MG. (2004). Pharmacokinetic changes in drugs during protein-calorie malnutrition: correlation between drug metabolism and hepatic microsomal cytochrome P450 isozymes. Arch Pharm Res 27:693–712.
   PubMed Web of Science ®Google Scholar
• Lee DY, Lee I, Lee MG. (2007). Effects of cysteine on the pharmacokinetic parameters of omeprazole in rats with protein-calorie malnutrition: partial restoration of some parameters to control levels by oral cysteine supplementation. JPEN J Parenter Enteral Nutr 31:37–46.
   PubMed Web of Science ®Google Scholar
• Leu BL, Huang JD. (1995). Inhibition of intestinal P-glycoprotein and effects on etoposide absorption. Cancer Chemother Pharmacol 35:432–436.
   PubMed Web of Science ®Google Scholar
• Li X, Yun JK, Choi JS. (2007). Effects of morin on the pharmacokinetics of etoposide in rats. Biopharm Drug Dispos 28:151–156.
   PubMed Web of Science ®Google Scholar
• Li C, Li X, Choi JS. (2009). Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats. Arch Pharm Res 32:133–138.
   PubMed Web of Science ®Google Scholar
• Lowry SF, Goodgame JT Jr, Norton JA, Jones DC, Brennan MF. (1977). Effect of protein malnutrition on host-tumor composition and growth. Surg Forum 28:143–145.
   PubMedGoogle Scholar
• Makhey VD, Guo A, Norris DA, Hu P, Yan J, Sinko PJ. (1998). Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm Res 15:1160–1167.
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis G, de Kanter R. (2006). Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine. Drug Metab Dispos 34:1047–1054.
   PubMed Web of Science ®Google Scholar
• Murakami T, Nakanishi M, Yoshimori T, Okamura N, Norikura R, Mizojiri K. (2003). Separate assessment of intestinal and hepatic first-pass effects using a rat model with double cannulation of the portal and jugular veins. Drug Metab Pharmacokinet 18:252–260.
   PubMedGoogle Scholar
• Obama M, Cangir A, van Eys J. (1983). Nutritional status and anthracycline cardiotoxicity in children. South Med J 76:577–578.
   PubMed Web of Science ®Google Scholar
• Piao YJ, Li X, Choi JS. (2008). Effects of verapamil on etoposide pharmacokinetics after intravenous and oral administration in rats. Eur J Drug Metab Pharmacokinet 33:159–164.
   PubMed Web of Science ®Google Scholar
• Senthilkumari S, Velpandian T, Biswas NR, Saxena R, Ghose S. (2008). Evaluation of the modulation of P-glycoprotein (P-gp) on the intraocular disposition of its substrate in rabbits. Curr Eye Res 33:333–343.
   PubMed Web of Science ®Google Scholar
• Sezer S, Ibis A, Ozdemir BH, Ozdemir FN, Külah E, Boyacioglu S, Haberal M. (2004). Association of helicobacter pylori infection with nutritional status in hemodialysis patients. Transplant Proc 36:47–49.
   PubMed Web of Science ®Google Scholar
• Shirazi FH, Bahrami G, Stewart DJ, Tomiak E, Delorme F, Noel D, Goel R. (2001). A rapid reversed phase high performance liquid chromatographic method for determination of etoposide (VP-16) in human plasma. J Pharm Biomed Anal 25:353–356.
   PubMed Web of Science ®Google Scholar
• Walker O, Dawodu AH, Salako LA, Alván G, Johnson AO. (1987). Single dose disposition of chloroquine in kwashiorkor and normal children–evidence for decreased absorption in kwashiorkor. Br J Clin Pharmacol 23:467–472.
   PubMed Web of Science ®Google Scholar
• Werle M, Hoffer M. (2006). Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release 111:41–46.
   PubMed Web of Science ®Google Scholar
• Wilkinson GR, Shand DG. (1975). A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18:377–390.
   PubMed Web of Science ®Google Scholar